logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Idera Pharmaceuticals (IDRA) Climbs on Positive Top-line Data from IMO-8400 Phase 2 Trial

By  +Follow March 27, 2014 11:11AM
Share:
Tickers Mentioned:

It’s been a wild week for Idera Pharmaceuticals (IDRA). What started as a modest decline on March 19 after the stock bumped against its rising resistance level at about $6.85 a share turned into a blood bath on Monday when Summer Street Research Partners analysts expressed skepticism about the effectiveness of IMO-8400, the company’s lead therapy. Shares plummeted, and kept falling throughout the week. However, while Thursday brought more losses, it also brought an opinion from Piper Jaffray analysts that ran counter to Summer Street, calling the sell-off premature and overblown.

Now, for the time being at least, it appears as though Piper Jaffray had the right idea. The stock is up over 10 percent in early trading after the release of top-line data from its Phase 2 trial for IMO-8400 that appears to be broadly positive.

Shares gapped up 16.2 percent to $4.51 a share at the opening bell, fell sharply to just under $4.30 immediately afterwards, then quickly began a buying run that pushed the stock as high as $4.75 a share just before 10am ET, a 22.4 percent gain. The stock retreated again, though, falling back below its opening price as the morning wore on.

The phase 2 trial was a double-blind placebo controlled clinical trial involving 32 patients with moderate-to-severe plaque psoriasis. Idera’s IMO-8400 met both the primary objective of evaluating safety and tolerability for the drug, with no treatment related discontinuation and all patients being well tolerated, and its secondary objective of demonstrating clinical activity in patients with psoriasis.

“Successful completion of this trial is an important additional milestone in our TLR antagonist program. We have studied psoriasis as the initial disease indication to demonstrate clinical proof of concept for our TLR antagonists in autoimmune diseases,” said CEO Sudhir Agrawal, D. Phil. “With these data, we can now pursue our announced business strategy and advance our TLR antagonist drug candidates for the treatment of orphan diseases with high unmet medical need. Towards this goal, our clinical development strategy for IMO-8400 is focused on B-cell lymphomas harboring the MYD88 L265P mutation, and on orphan autoimmune disease indications. Over the remainder of 2014, we anticipate enrolling patients in IMO-8400 trials for Waldenström’s macroglobulinemia, diffuse large B-cell lymphoma and polymyositis and dermatomyositis.”

The treatment showed effectiveness and tolerability at three different dosing levels, giving Idera executives reason for optimism.

“We are very pleased to have met the goals of this trial related to safety and tolerability over three months of dosing, and to have obtained evidence of clinical activity with IMO-8400 in psoriasis patients. This provides further validation of the scientific rationale of blocking over-activation of specific TLRs,” said Senior VP and CMO Lou Brenner, 41M.D. “These data also support our clinical development plans for IMO-8400 in genetically defined forms of B-cell lymphoma and orphan autoimmune diseases.”

However, Summer Street analysts appeared to double down on their initial claims about IMO-8400. Analyst Bart Classen observed that did not mention a dosing effect in the recently-released data, something he considered surprising given it was a dosing study and some patients had very low doses.

The day’s gains may also have generated some interesting technical factors for Idera’s stock. While the release of clinical data is clearly what’s fueling the day’s movement, these other factors could be contributing to the strength of the rebound.

The stock has shown a 14-day stochastic RSI below 0.20 since plunging on Monday, a sign that it’s oversold. And as of yesterday’s losses, the 14-day RSI had also dropped below 30, another sign recognized by traders that the stock is oversold. What’s more, Friday’s gains resulted in the signal line crossing the MACD, which is considered a buy sign.

Finally, the fact that the stock bottomed out at just under $3.70 could show the formation of a rising support line at just under $4 a share based on a hard bounce there in late January. This would play against a clearly defined rising resistance line that’s appeared to cap gains since early September of last year. However, given that this supposed support line would be based on only two bounces, one of which corresponds with the release of positive clinical data, it’s hard to place all that much reliance in it.

 

 

Editor's note: this article had previously referred to Summer Street Research Partners as Summer Street Capital Partners, a separate and unafilliated company. It has been edited to correct this mistake.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for IDRA
OTPicks.com
20 Sep 14 16:10:33
http://t.co/hjgLwIcNgz lookn4wins: $IDRA Stock Chart $IDRA Most recent stock chart: lookn4wins http://t.co/pfDDNLX9xa http://t.co/hjgLwIcNgz
OTPicks.com
20 Sep 14 16:10:30
http://t.co/QkCFZ8H3V8 lookn4wins: $IDRA Stock Chart $IDRA Most recent stock chart: lookn4wins http://t.co/6xGuR1hSD5 http://t.co/QkCFZ8H3V8
leahanne
20 Sep 14 10:19:20
$IYR DJ US Real Estate Ishares (IYR) 70.95 +0.04 (+0.06%) $BBBY $VIPS $IDRA http://t.co/xj8JqC0Sf3
Investors Hangout
20 Sep 14 10:15:58
lookn4wins: $IDRA Stock Chart $IDRA Most recent stock chart http://t.co/fpRFlCREUH
Investors Hangout
20 Sep 14 10:15:53
lookn4wins: $IDRA Stock Chart $IDRA Most recent stock chart http://t.co/9kbyauxWgH
Extreme Stocks
20 Sep 14 10:10:35
lookn4wins: $IDRA Stock Chart $IDRA Most recent stock chart http://t.co/juwSFVDuXW
lookn4wins
20 Sep 14 10:10:27
$IDRA Stock Chart $IDRA Most recent stock chart and technical analysis. $IYT $USO $DIS $INVN $UNH $TVIX http:/ http://t.co/MIyoFU2PlC
Investors Hangout
20 Sep 14 08:43:35
lookn4wins: $IDRA 50 Simple Moving Average $IDRA Most recent http://t.co/PhecWFT7e9
Investors Hangout
20 Sep 14 08:43:35
lookn4wins: $IDRA 50 Simple Moving Average $IDRA Most recent http://t.co/8yCrx08td1
Stockaholics
20 Sep 14 08:38:11
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $QCOR $FCEL $IDRA
Jake13
20 Sep 14 08:28:53
$SLV Sell? Click here to find out if $SLV is a buy hold or sell. Watching these stocks. $NNLX $IDRA $UGAZ $MFC http://t.co/uCkviXgHsq
Extreme Stocks
20 Sep 14 08:25:15
lookn4wins: $IDRA 50 Simple Moving Average $IDRA Most recent http://t.co/ewcsJTNSGd
lookn4wins
20 Sep 14 08:13:35
$IDRA 50 Simple Moving Average $IDRA Most recent stock chart and technical analysis. $NEWL $ACAD $SH $AGCO $CJ http://t.co/BCkQ3lWtET
lookn4wins
20 Sep 14 06:36:27
$LNKD Volume $LNKD Most recent stock chart and technical analysis. $IDRA $QLD $IYR $SDRL $PFE $TBT http://stoc http://t.co/MsWGdWpjpM
Stockaholics
20 Sep 14 00:03:10
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $QCOR $FCEL $IDRA
Stock Rocket
19 Sep 14 12:51:55
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $QCOR $FCEL $IDRA
Daily Contracts
19 Sep 14 10:53:01
Real-Time feed of company contracts, original agreements and executive updates from Idera Pharmaceuticals $IDRA http://t.co/eSs9DV89f0
Leo Kolivakis
19 Sep 14 10:38:37
Keep buying these small cap bios as they sell off: $BCRX, $IDRA, $PGNX, $SGYP, $THLD, and $XOMA. Today it's all about $BABA! -:)
703trader
19 Sep 14 09:40:54
$IDRA baker bros must be selling position
Trader Pete
19 Sep 14 09:36:22
added more $IDRA @ 2.46 ... swing trade, looking for 2.85+ in 5-10 trading days
Scott Thomas
19 Sep 14 09:35:54
$IDRA is a sad firm . Its always next quarter . $2.45 ...price tells a story imo
DCam
19 Sep 14 08:18:36
$IDRA back in lower range of its $2.50 to $3.00 box. I got burned doing this with $SGYP last week so will hold off http://t.co/avJ12rbCCp
Trader Pete
19 Sep 14 08:11:06
$IDRA ... long 2.50 for a swing ... looking for 2.85 in next 5-10 trading days
WaterMartyr
19 Sep 14 08:10:21
No position, but $IDRA is swearing at long term support. Not interested in the risk below. Been wrong many times though. #WaterMartyr
Grant Hoffner
19 Sep 14 05:28:48
Seeing a lot of accumulation on $IDRA. One of my two lt small cap bios.
Stock Rocket
19 Sep 14 02:45:10
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $QCOR $FCEL $IDRA
Stock Rocket
19 Sep 14 00:16:28
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $QCOR $FCEL $IDRA
Stock Rocket
18 Sep 14 21:23:25
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/h5N34SPJ6o $QCOR $FCEL $IDRA
TravelingFam4
18 Sep 14 04:27:21
Listening to $ISIS CEO on @jimcramer last night has me even more excited about the future of $IDRA & the improved antisense technology
Stock Rocket
17 Sep 14 23:47:20
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/h5N34SPJ6o $QCOR $FCEL $IDRA
chartguy89
17 Sep 14 23:28:39
IDRA 2.57 Stock Charts $IDRA Idera Pharmaceuticals Inc. (NASDAQ) Last Updated: 09/18/2014 01:28:45 IDRA Stock http://t.co/arrt8vsmYJ
Small Cap Strategist
17 Sep 14 16:41:16
Most searched small-cap stocks, Wed Sept 17th - $MOBI $WETF $FOLD $HALO $CNCE $PEIX $AXAS $IDRA - More: http://t.co/1znvSOIJVT - #smallcap
Stock Rocket
17 Sep 14 12:54:40
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $QCOR $FCEL $IDRA
JMS
17 Sep 14 12:39:22
RT @VisualStockR: $IDRA - Confidential Treatment Order (ct Order) http://t.co/CEPMVRDhgJ
ThinkNWaves
17 Sep 14 11:13:45
RT @psuvafan007: Bacteria Boost Viral Vaccine Response http://t.co/HzuikXfbSy Toll-Like Receptors #TLR #immunostimulant #imiquimod $DVAX $A…
StockNews
17 Sep 14 10:46:21
$IDRA - Confidential Treatment Order (ct Order) http://t.co/g5a03lMEAR
Pzaa...Guy
17 Sep 14 10:46:16
$IDRA - Confidential Treatment Order (ct Order) http://t.co/0PEq47Qeap
VisualStock Resource
17 Sep 14 10:46:13
$IDRA - Confidential Treatment Order (ct Order) http://t.co/CEPMVRDhgJ
Stockaholics
17 Sep 14 10:46:03
$RSII gained 150% in 4 days! Get our top penny stock picks early: http://t.co/iSqL7zgTT1 $QCOR $FCEL $IDRA
chartguy89
17 Sep 14 10:17:56
IDRA 2.57 Stock Charts $IDRA Idera Pharmaceuticals Inc. (NASDAQ) Last Updated: 09/17/2014 12:18:00 IDRA Stock http://t.co/aFpsMHqAq1
KiesenBiker
17 Sep 14 09:48:37
RT @psuvafan007: Bacteria Boost Viral Vaccine Response http://t.co/HzuikXfbSy Toll-Like Receptors #TLR #immunostimulant #imiquimod $DVAX $A…
Dr. Zoidberg
17 Sep 14 09:47:20
Bacteria Boost Viral Vaccine Response http://t.co/HzuikXfbSy Toll-Like Receptors #TLR #immunostimulant #imiquimod $DVAX $ARWR $GSK $IDRA
Crazy kid
17 Sep 14 06:41:35
Commented on StockTwits: "@RangeFinder: $IDRA I see more red tomorrow. Yeah, I think maybe a pale turquoise might... http://t.co/OWNVK2vg9c
Stockaholics
16 Sep 14 20:10:19
Our Platinum Penny Stock Picks, Gained 90% In The Past 2 Days! Get our next pick early: http://t.co/hep0lGZUgZ $QCOR $FCEL $IDRA
Stockaholics
16 Sep 14 12:25:04
$BRNW Ran Up 145% So Far Today! Huge News: http://t.co/0NGNmaYblA $QCOR $FCEL $IDRA
Stockaholics
16 Sep 14 10:48:19
$BRNW Ran Up 145% So Far Today! Huge News: http://t.co/agBJ7Ngnzq $QCOR $FCEL $IDRA
Stockaholics
16 Sep 14 01:00:33
$AZFL Gained 68.2% In Just 3 Days, After Our Penny Stock Alert! Huge Update: http://t.co/f6EXGyxEe9 $QCOR $FCEL $IDRA
Stockaholics
15 Sep 14 18:40:46
Our SECRET Alert on $INOH Closed Up 60% For Platinum Members Today! Major News: https://t.co/HzD6J3YtmW $QCOR $FCEL $IDRA
Stockaholics
15 Sep 14 15:21:33
Our SECRET Alert on $INOH Closed Up 60% For Platinum Members Today! Major News: https://t.co/HzD6J3YtmW $QCOR $FCEL $IDRA
work1411
15 Sep 14 13:24:14
@BioInvestor2013 Been watching $OPXA $OXGN $VICL $IDRA $BIOD $GERN- all been going cheaper & struggling. No entry yet.
				
				
By  +Follow March 27, 2014 11:11AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.